Ex Vivo and In Vitro Studies Revealed Underlying Mechanisms of Immature Intestinal Inflammatory Responses Caused by Aflatoxin M1 Together with Ochratoxin A

Ziwei Wang, Yanan Gao, Shengnan Huang, Jiaqi Wang, Nan ZhengToxins 2022 · DOI

TL;DR

This study investigates how two common food contaminants, Aflatoxin M1 (AFM1) and Ochratoxin A (OTA), trigger inflammatory responses in immature intestines. They found OTA is a stronger inflammatory trigger than AFM1, primarily by activating the NF-κB pathway, while AFM1 has a less pronounced effect. Understanding these mechanisms is crucial for protecting infant gut health.

What Problem Does This Paper Address?

Infants are particularly vulnerable to the toxic effects of mycotoxins, such as AFM1 and OTA, which can be found in milk and baby foods. These toxins can reach the gastrointestinal tract and potentially impair the developing immune system and intestinal tissue. While the inflammatory effects of these toxins on mature systems are somewhat understood, there's a significant knowledge gap regarding their impact on immature intestines, which have unique developmental characteristics and higher susceptibility. This paper aims to bridge that gap by elucidating the specific mechanisms by which AFM1 and OTA, individually and in combination, induce inflammation in immature intestinal models.

Methods

The researchers employed a multi-pronged approach combining ex vivo and in vitro techniques:

  • Ex Vivo Gut Tissue Culture: Fetal mouse jejunum tissues were cultured to assess the direct inflammatory response to AFM1 and OTA. This involved measuring the release of key inflammatory cytokines like IL-6 and TNF-α using ELISA.
  • RNA Sequencing (RNA-seq): This high-throughput technique was used to analyze the global gene expression patterns in the ex vivo jejunum tissues treated with the toxins. This allowed for the identification of affected pathways and potential "hub genes" involved in the inflammatory response.
  • Weighted Gene Co-expression Network Analysis (WGCNA): This systems biology approach was used to cluster genes with similar expression patterns, helping to identify key biological processes and modules significantly impacted by the toxins.
  • Protein-Protein Interaction (PPI) Network Analysis: This was used to identify potential "hub genes" within the identified inflammatory pathways, focusing on genes with high connectivity and likely central roles.
  • In Vitro Cell Culture: A human fetal intestinal cell line (FHs 74 Int) was used to further investigate the cellular mechanisms. This included assessing cell viability (CCK-8 assay), measuring cytokine production (ELISA), quantifying gene expression (RT-qPCR), and examining protein levels and cellular localization (Western blotting).
  • Reactive Oxygen Species (ROS) Measurement: The role of oxidative stress in the inflammatory response was investigated by measuring intracellular ROS levels.
  • NF-κB Pathway Analysis: Specific focus was placed on the NF-κB pathway, a critical regulator of inflammation, by examining the degradation of IκBα, the expression and translocation of NF-κB subunits (p50 and RelB), and the impact of a ROS inhibitor (NAC).

Datasets

The study utilized two primary biological models:

  • Ex vivo CD-1 fetal mouse jejunum tissues: These were used for initial assessment of cytokine release and global gene expression analysis via RNA-seq.
  • Human fetal small intestinal epithelial FHs 74 Int cell line: This cell line was used for detailed in vitro mechanistic studies, including viability, cytokine expression, and NF-κB pathway activation.

No new benchmark datasets were introduced.

Key Insights and Ideas

  • OTA is a Potent Inflammatory Trigger in Immature Intestines: The study strongly suggests that OTA is a more potent inducer of inflammation in immature intestinal models compared to AFM1. This is evident in both cytokine release from ex vivo tissues and cellular responses in the FHs 74 Int cell line.
  • Antagonistic Interaction Between AFM1 and OTA: Interestingly, when combined, AFM1 and OTA did not show synergistic effects. Instead, they appeared to exert antagonistic actions, particularly in cytokine release, suggesting a complex interplay that warrants further investigation.
  • NF-κB Pathway is Central to OTA-Induced Inflammation: The research highlights the NF-κB pathway as a key mediator of OTA's inflammatory effects. OTA significantly upregulates NF-κB components and promotes their translocation to the nucleus, driving downstream inflammatory gene expression. AFM1, on the other hand, showed a much weaker impact on this pathway.
  • Oxidative Stress as a Mechanism for OTA: The study provides evidence that OTA-induced inflammation is linked to increased reactive oxygen species (ROS) production. Inhibiting ROS partially reversed the inflammatory response, suggesting oxidative stress is a significant contributing factor to OTA's pro-inflammatory action.
  • Hub Genes Identified: Through transcriptomic and network analysis, NFKB1 and RelB were identified as crucial "hub genes" in the inflammatory response to OTA, underscoring their central role in mediating the toxin's effects.

Key Results

  • Cytokine Release: OTA (4 µM) induced significantly higher IL-6 release from jejunum tissues than AFM1 (50 µM). Both toxins decreased IL-10 levels. OTA also significantly increased TNF-α, while AFM1 had a dose-independent effect.
  • Gene Expression: RNA-seq revealed that OTA and the AFM1+OTA combination dramatically altered gene expression patterns, with thousands of differentially expressed genes. The "cytokine-cytokine receptor interaction" pathway was significantly enriched in the OTA group.
  • Cell Viability: OTA significantly reduced FHs 74 Int cell viability at lower concentrations than AFM1. The combination of AFM1 and OTA also showed a significant reduction in viability.
  • NF-κB Activation: OTA and AFM1+OTA treatments significantly induced IκBα degradation, leading to the nuclear translocation of NF-κB (p50/RelB dimer) in FHs 74 Int cells. OTA significantly upregulated NFKB1 and RelB mRNA, while AFM1 had no obvious impact.
  • ROS Production: OTA and AFM1+OTA significantly increased intracellular ROS production in FHs 74 Int cells, with OTA showing a more pronounced effect.

Limitations and Future Work

The authors acknowledge several limitations and suggest avenues for future research:

  • Detailed Toxicokinetics: The precise metabolic pathways and cellular uptake mechanisms of AFM1 and OTA in fetal intestinal cells are not fully understood. Further research is needed to elucidate these processes.
  • Causal Relationships: While strong correlations were found, clarifying the direct causal relationships between toxin exposure, NF-κB activation, and downstream inflammatory signals requires more investigation.
  • Synergistic/Antagonistic Mechanisms: The observed antagonistic interaction between AFM1 and OTA needs deeper exploration. Understanding the molecular basis for this competition (e.g., shared transport mechanisms or competing for cellular targets) is crucial.
  • In Vivo Relevance: While ex vivo and in vitro models provide valuable insights, further studies are needed to confirm these findings in living organisms and to understand the long-term consequences of such exposures.
  • Metabolic Transformations: The study mentions that mycotoxins can be metabolized into various forms. Investigating the specific roles of these metabolites in inducing inflammation is an important future direction.
  • Protein Translation and Post-translational Modifications: The authors note that these processes can be altered by AFM1 and OTA, and their impact on inflammation is not fully explored.

Summary updated

Abstract

Aflatoxin M1 (AFM1) and ochratoxin A (OTA), which are occasionally detected in milk and commercial baby foods, could easily enter and reach the gastrointestinal tract, posing impairment to the first line of defense and causing dysfunction of the tissue. The objective of this study was to investigate the immunostimulatory roles of individual and combined AFM1 and OTA on the immature intestine. Thus, we used ELISA assays to evaluate the generation of cytokines from ex vivo CD-1 fetal mouse jejunum induced by AFM1 and OTA and explored the related regulatory pathways and pivot genes using RNA-seq analysis. It was found that OTA exhibited much stronger ability in stimulating pro-inflammatory cytokine IL-6 from jejunum tissues than AFM1 (OTA of 4 μM versus AFM1 of 50 μM), whereas the combination of the two toxins seemed to exert antagonistic actions. In addition, transcriptomics also showed that most gene members in the enriched pathway 'cytokine-cytokine receptor interaction' were more highly expressed in OTA than the AFM1 group. By means of PPI network analysis, NFKB1 and RelB were regarded as hub genes in response to OTA but not AFM1. In the human FHs 74 Int cell line, both AFM1 and OTA enhanced the content of reactive oxygen species, and the oxidative response was more apparent in OTA-treated cells in comparison with AFM1. Furthermore, OTA and AFM1 + OTA raised the protein abundance of p50/RelB, and triggered the translocation of the dimer from cytosol to nucleus. Therefore, the experimental data ex vivo and in vitro showed that OTA-induced inflammation was thought to be bound up with the up-regulation and translocation of NF-κB, though AFM1 seemed to have no obvious impact. Since it was the first attempt to uncover the appearances and inner mechanisms regarding inflammation provoked by AFM1 and OTA on immature intestinal models, further efforts are needed to understand the detailed metabolic steps of the toxin in cells and to clarify their causal relationship with the signals proposed from current research.
BibTeX
@inproceedings{wang2022ex,
  author = {Ziwei Wang and Yanan Gao and Shengnan Huang and Jiaqi Wang and Nan Zheng},
  title = {{Ex Vivo and In Vitro Studies Revealed Underlying Mechanisms of Immature Intestinal Inflammatory Responses Caused by Aflatoxin M1 Together with Ochratoxin A}},
  booktitle = {Toxins},
  year = {2022},
  doi = {10.3390/toxins14030173},
}
Figure